Aging
Navigate
Research Paper|Volume 12, Issue 13|pp 13740—13761

Cognitive enhancement of healthy older adults using hyperbaric oxygen: a randomized controlled trial

Amir Hadanny1,2,3, Malka Daniel-Kotovsky1, Gil Suzin1, Rahav Boussi-Gross1, Merav Catalogna1, Kobi Dagan1, Yafit Hachmo5, Ramzia Abu Hamed1, Efrat Sasson1, Gregory Fishlev1, Erez Lang1, Nir Polak1, Keren Doenyas1, Mony Friedman1, Sigal Tal4, Yonatan Zemel1, Yair Bechor1, Shai Efrati1,2,5,6
  • 1The Sagol Center for Hyperbaric Medicine and Research, Shamir (Assaf-Harofeh) Medical Center, Zerifin, Israel
  • 2Sackler School of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  • 3The Mina and Everard Goodman Faculty of Life Sciences, Bar Ilan University, Ramat-Gan, Israel
  • 4Radiology Department, Shamir Medical Center, Zerifin, Israel
  • 5Research and Development Unit, Shamir Medical Center, Zerifin, Israel
  • 6Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv, Israel
Received: May 6, 2020Accepted: June 9, 2020Published: June 26, 2020

Copyright © 2020 Amir et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

More than half of community-dwelling individuals sixty years and older express concern about declining cognitive abilities. The current study’s aim was to evaluate hyperbaric oxygen therapy (HBOT) effect on cognitive functions in healthy aging adults.

A randomized controlled clinical trial randomized 63 healthy adults (>64) either to HBOT(n=33) or control arms(n=30) for three months. Primary endpoint included the general cognitive function measured post intervention/control. Cerebral blood flow (CBF) was evaluated by perfusion magnetic resonance imaging.

There was a significant group-by-time interaction in global cognitive function post-HBOT compared to control (p=0.0017). The most striking improvements were in attention (net effect size=0.745) and information processing speed (net effect size=0.788).

Voxel-based analysis showed significant cerebral blood flow increases in the HBOT group compared to the control group in the right superior medial frontal gyrus (BA10), right and left supplementary motor area (BA6), right middle frontal gyrus (BA6), left middle frontal gyrus (BA9), left superior frontal gyrus (BA8) and the right superior parietal gyrus (BA7).

In this study, HBOT was shown to induce cognitive enhancements in healthy aging adults via mechanisms involving regional changes in CBF. The main improvements include attention, information processing speed and executive functions, which normally decline with aging.